what's VitaRNA?

VitaRNA is a tokenized intellectual property non-fungible token (IP-NFT) representing ownership and governance rights in Artan Bio's gene therapy research. The project focuses on developing therapeutic candidates that target nonsense mutations at the RNA level to address aging-related genetic factors. By tokenizing the IP, VitaRNA enables community-driven funding and decision-making, allowing token holders to vote on research directions, capital allocation, and development milestones. Launched through VitaDAO, VitaRNA raised over $300,000 via a crowdsale to advance preclinical work toward clinical trials. The token operates on blockchain infrastructure provided by Molecule, facilitating onchain trading, tracking, and exploration of the project's progress. Artan Bio, led by experienced biotech entrepreneurs, aims to suppress mutations driving aging, positioning VitaRNA as a pioneering effort in decentralized science (DeSci) where collective ownership accelerates innovation in longevity research. The mechanics involve IP-NFT structure, where the underlying patents and research data are governed transparently onchain. Holders participate in a DAO-like model, influencing R&D from patent registration to trial design, democratizing access to high-impact biotech typically gated by traditional venture capital.

VitaRNA lead's prior company acquired by Eli Lilly; VitaDAO backs aging gene therapy research.

contract